SC 13G/A: Concentra Group Holdings Parent, Inc.
Ticker: CON · Form: SC 13G/A · Filed: Nov 27, 2024 · CIK: 2014596
| Field | Detail |
|---|---|
| Company | Concentra Group Holdings Parent, INC. (CON) |
| Form Type | SC 13G/A |
| Filed Date | Nov 27, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Concentra Group Holdings Parent, Inc..
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G/A filing submitted by Concentra Group Holdings Parent, INC. (ticker: CON) to the SEC on Nov 27, 2024.
What is the risk level of this SC 13G/A filing?
This filing has been assessed as low risk.
What are the key financial figures in this filing?
Key dollar amounts include: $0.01 (me of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securiti).
How long is this filing?
Concentra Group Holdings Parent, INC.'s SC 13G/A filing is 2 pages with approximately 512 words. Estimated reading time is 2 minutes.
Where can I view the full SC 13G/A filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 512 words · 2 min read · ~2 pages · Grade level 9.5 · Accepted 2024-11-27 16:01:21
Key Financial Figures
- $0.01 — me of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securiti
Filing Documents
- tm2429618d1_sc13ga.htm (SC 13G/A) — 24KB
- 0001104659-24-123669.txt ( ) — 26KB
Ownership
Item 4. Ownership. (a) through (c): The information requested in these paragraphs is incorporated by reference to the cover page to this Amendment No. 1 to Schedule 13G.
Ownership of Five Percent
Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that the Reporting Person has ceased to be the beneficial owner of more than five percent of the Common Stock, check the following: SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: November 27, 2024 SELECT MEDICAL CORPORATION By: /s/ Michael E. Tarvin Name: Michael E. Tarvin Title: Senior Executive Vice President, General Counsel & Secretary